- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT03374891
A Multicenter Trial of a Shared DECision Support Intervention for Patients Offered Implantable Cardioverter-DEfibrillators
DECIDE - ICD: A Multicenter Trial of a Shared DECision Support Intervention for Patients Offered Implantable Cardioverter-DEfibrillators
연구 개요
상세 설명
The investigators propose the DECIDE-ICD trial: a type II effectiveness implementation hybrid trial of the investigators ICD PtDAs. The Investigators will use a 6-site stepped-wedge design, with implementation guided by normalization process theory® and evaluation guided by the RE-AIM framework.
The investigators aim to evaluate reach and effectiveness of the ICD PtDAs using a pragmatic, stepped-wedge design on decision quality (knowledge and value-concordance) and psychosocial outcomes.
- Hypothesis 1a: PtDAs will reach over 50% of eligible patients.
- Hypothesis 1b: ICD PtDAs will be effective in improving decision quality in real-world practice.
- Hypothesis 1c: Better informed patients will have lower anxiety, higher rates of planning for the possibility of deactivation, and increased identification of a surrogate decision maker.
The investigators propose 3 a priori hypotheses:
- The decision aids will have a differential effect on the decisions of participants by age (>= 70 years old vs <70 years old);
- The decision aids will have a differential effect on the decisions of participants by heart failure type (non-ischemic vs ischemic);
- The decision aids will have a differential effect on the decisions of participants by the type of device they are considering (ICD vs ICD replacement vs CRT-D).
Along with these hypotheses, we recognize that other important covariates exist, such as health literacy and education level.
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
Colorado
-
Aurora, Colorado, 미국, 80045
- University of Colorado Denver
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- 18 years or older
- English-speaking (videos and surveys have only been validated in English)
- Patients have been offered a primary prevention ICD for initial implant, reimplantation, or CRT with defibrillation
Exclusion Criteria:
- Prisoners
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 지지 요법
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
간섭 없음: Participants will fill out surveys
These participants will fill out surveys in regard to their experiences, opinions, and knowledge of the defibrillator process.
|
|
|
활성 비교기: Educational video and/or handout
These participants will receive an educational video and/or handout about the defibrillator process.
Then they will fill out surveys in regard to their experiences, opinions, and knowledge of the defibrillator process.
|
The intervention includes a video and/or handout (whichever is easier for the participant) that will give information about defibrillators and about other patients' experiences with their decisions about defibrillators.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Knowledge About Defibrillation at Baseline
기간: Baseline
|
Multiple survey responses by participants will indicate knowledge changes over time.
The Decision Quality Knowledge Survey measures knowledge about defibrillators.
Possible scores range from 0 to 100, with higher scores indicating more knowledge and better outcomes.
|
Baseline
|
|
Knowledge About Defibrillation at 1 Month
기간: 1 month
|
Multiple survey responses by participants will indicate knowledge changes over time.
The Decision Quality Knowledge Survey measures knowledge about defibrillators.
Possible scores range from 0 to 100, with higher scores indicating more knowledge and better outcomes.
|
1 month
|
|
Knowledge About Defibrillation at 6 Months
기간: 6 months
|
Multiple survey responses by participants will indicate knowledge changes over time.
The Decision Quality Knowledge Survey measures knowledge about defibrillators.
Possible scores range from 0 to 100, with higher scores indicating more knowledge and better outcomes.
|
6 months
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Reach of Eligible Patients
기간: Baseline
|
Measuring how many patients of the eligible patient base are able to view or read the educational materials.
|
Baseline
|
기타 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Differential Effect by Age
기간: Baseline, 1 month, 6 months
|
The decision aids will have a differential effect on the decisions of participants by age (>= 70 years old vs <70 years old)
|
Baseline, 1 month, 6 months
|
|
Differential Effect by Heart Failure Type
기간: Baseline, 1 month, 6 months
|
The decision aids will have a differential effect on the decisions of participants by heart failure type (non-ischemic vs ischemic)
|
Baseline, 1 month, 6 months
|
|
Differential Effect by Type of Device
기간: Baseline, 1 month, 6 months
|
The decision aids will have a differential effect on the decisions of participants by the type of device they are considering (ICD vs ICD replacement vs CRT-D).
|
Baseline, 1 month, 6 months
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Daniel D Matlock, MD, MPH, University of Colorado, Denver
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
심부전에 대한 임상 시험
-
Fondation Hôpital Saint-Joseph모병
-
Medical University of BialystokMedical University of Lodz; Poznan University of Medical Sciences; Nicolaus Copernicus University 그리고 다른 협력자들종료됨심부전, 수축기 | 박출률이 감소된 심부전 | 심부전 New York Heart Association Class IV | 심부전 New York Heart Association Class III폴란드
-
Novartis Pharmaceuticals완전한핵심 연구의 12개월 치료 기간을 성공적으로 완료한 환자(de Novo Heart Recipients)는 EC-MPS 치료에 관심이 있었습니다.
-
University of WashingtonAmerican Heart Association완전한심부전,울혈 | 미토콘드리아 변경 | 심부전 New York Heart Association Class IV미국